Answer these 15 questions to identify whether your next step should be route clarification, supplier diligence, commercial comparison or controlled implementation. Score each answer from 0 to 3, for a maximum of 45 points. Five mandatory evidence gates override the total: strong pricing and operations cannot compensate for unresolved route eligibility, licensing, quality, clinical handling or health-data controls.
For: US weight-management and telehealth providers with 10–100 prescribers, particularly multi-state organisations with a supplier decision within six months.
Complete with: procurement or operations, finance, the medical director, and legal/compliance. Include security or technology leadership for data-sharing and integration questions.
Research review date: November 17, 2026.
This is a desk-developed procurement assessment, not a validated risk model, supplier accreditation, legal opinion or clinical assessment. Its points and thresholds are editorial decision rules—not regulatory standards or measured industry benchmarks. A high score does not establish that a preparation is lawful, a supplier is safe or treatment will be uninterrupted.
Sources cited on this page
See the section’s source register for the research context.
Section sources →